fair point and that is the reason the sp is struggling to even reacg double digits. Fda clearance doesnt have any value unless sales is there … its no point valuating ldx at 0.17 upon fda clearance, all we need is solid sales and positive cash flow to be anywhere near 20c in future
fair point and that is the reason the sp is struggling to even...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $14.92M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.2¢ | 3.0¢ | $59.53K | 1.912M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1117600 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 490000 | 4 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| LDX (ASX) Chart |